Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
For the six months, sales was EUR 53.53 million compared to EUR 60.86 million a year ago. Net income was EUR 2.6 million compared to EUR 5.37 million a year ago. Basic earnings per share from continuing operations was EUR 0.37 compared to EUR 1.06 a year ago. Diluted earnings per share from continuing operations was EUR 0.37 compared to EUR 1.06 a year ago. Basic earnings per share was EUR 0.43 compared to EUR 0.89 a year ago.